Features of the clinical course of pneumonia caused by carbapenem-resistant strains of Klebsiella pneumoniae, resistant and sensitive to antibiotic combinations
AbstractThe purpose. To compare clinical and laboratory parameters and outcomes of pneumonia caused by carbapenem-resistant strains of Klebsiella pneumoniae depending on their sensitivity to antibiotic combinations.
Material and methods. A retrospective case-control study was conducted. The main group consisted of 25 people with pneumonia caused by K. pneumoniae with resistance to the combination of meropenem/amikacin/colistin, the control group – 25 patients with pathogen sensitivity to this combination. Clinical and laboratory data, concomitant diseases, treatment regimens, and disease outcomes were analyzed. Statistical processing of the obtained data was carried out using the Statistica 12.5 software package.
Results and discussion. Pneumonia caused by carbapenem-resistant strains of K. pneumoniae with resistance to the combination of meropenem/amikacin/colistin was characterized by more severe course, a high proportion of patients treated in the intensive care unit, and a higher risk of death.
Conclusion. The results of the study have practical significance in assessing the severity of the condition of a patient with K. pneumonia, indications for timely transfer to intensive care units and correction of antibacterial therapy.
Keywords: pneumonia; Klebsiella pneumonia; antibiotic resistance; carbapenem resistance
Funding. The work was financially supported by the Belarusian Republican Foundation for Fundamental Research (grant No. M23M-106).
Conflict of interest. The authors declare no conflict of interest.
Contribution. Conducting the study – Levchenko K.V.; collection of material – Levchenko K.V., Karpova E.V., Chmyhova I.A.; development of study design, data processing – Levchenko K.V., Mitsura V.M., Tapalski D.V.; writing the text – Levchenko K.V., Mitsura V.M.; text editing – Levchenko K.V., Mitsura V.M., Tapalski D.V., Bondarenko V.N., Karpova E.V. All authors confirm that their authorship meets the international ICMJE criteria (all authors made a significant contribution to the development of the concept, conduct of the study and preparation of the article, read and approved the final version before publication).
For citation: Levchenko K.V., Mitsura V.M., Tapalski D.V., Karpova E.V., Bondarenko V.N., Chmyhova I.A. Features of the clinical course of pneumonia caused by carbapenem-resistant strains of Klebsiella pneumoniae, resistant and sensitive to antibiotic combinations. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2025; 14 (1): 48–54. DOI: https://doi.org/10.33029/2305-3496-2025-14-1-48-54 (in Russian)
References
- Tang K.W., Millar B.C., Moore J.E. Antimicrobial Resistance (AMR). Br J Biomed Sci. 2023; 80: 11387. DOI: https://doi.org/10.3389/bjbs.2023.11387 PMID: 37448857.
- Aloke C., Achilonu I. Coping with the ESKAPE pathogens: evolving strategies, challenges and future prospects. Microb Pathog. 2023; 175: 105963. DOI: https://doi.org/10.1016/j.micpath.2022.105963 PMID: 36584930.
- Loyola-Cruz M.A., Gonzalez-Avila L.U., Martinez-Trejo A., et al. ESKAPE and beyond: the burden of coinfections in the COVID-19 pandemic. Pathogens. 2023; 12 (5): 743. DOI: https://doi.org/10.3390/pathogens12050743 PMID: 37242413.
- Yusof R.С., Norhayati M.N., Azman Y.M. Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis. PeerJ. 2023; 26 (11): 15265. DOI: https://doi.org/10.7717/peerj.15265
- Choi M.H., Kim D., Lee K.H., Cho J. H., et al. Changes in the prevalence of pathogens causing hospital-acquired bacterial pneumonia and the impact of their antimicrobial resistance patterns on clinical outcomes: a propensity-score-matched study. Int J Antimicrob Agents. 2023; 62 (3): 106886. DOI: https://doi.org/10.1016/j.ijantimicag.2023.106886
- Ashurst J.V., Dawson A. Klebsiella pneumonia. URL: https://www.ncbi.nlm.nih.gov/books/NBK519004 (дата обращения: 19.06.2024).
- Li L., Li S., Wei X., Lu Z., et al. Infection with Carbapenem-resistant hypervirulent Klebsiella pneumoniae: clinical, virulence and molecular epidemiological characteristics. Antimicrob Resist Infect Control. 2023; 12 (124). DOI: https://doi.org/10.1186/s13756-023-01331‑y
- Fasciana T., Antonelli A., Bianco G., Lombardo D., et al. Multicenter study on the prevalence of colonization due to carbapenem-resistant Enterobacterales strains before and during the first year of COVID-19, Italy 2018–2020. Front Public Health. 2023; 11: 1270924. DOI: https://doi.org/10.3389/fpubh.2023.1270924
- Zaki H.A., Hamdi A.B., Shaban E. Hussein E.М., et al. The battle of the pneumonia predictors: a comprehensive meta-analysis comparing the pneumonia severity index (PSI) and the CURB-65 score in predicting mortality and the need for ICU support. Cureus. 2023; 15 (7): 42672. DOI: https://doi.org/10.7759/cureus.42672
- Antonova E.G., Zhyl’tsou I.V., Stakhovich I.I. Antibacterial therapy of hospital infections caused by carbapenemase-producing strains of pneumoniae. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta [Bulletin of the Vitebsk State Medical University]. 2022; 21 (3): 69–76. DOI: https://doi.org/10.22263/2312-4156.2022.3.69 (in Russian)
- Vitiello А., Sabbatucci М., Boccellino М., Zovi A., et al. Therapeutic and unconventional strategies to contrast antimicrobial resistance: a literature review. Discov Med. 2023; 35 (178): 750–6. DOI: https://doi.org/10.24976/Discov.Med.202335178.70
- Tapal’sky D.V. Susceptibility to antibiotic combinations among nosocomial carbapenemase-producing Gram-negative bacteria isolated in Belarus. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya [Clinical Microbiology and Antimicrobial Chemotherapy]. 2018; 20 (3): 182–91. DOI: https://doi.org/10.36488/cmac.2018.3.182191 (in Russian)
- Breakpoint tables for interpretation of MICs and zone diameters. Version. 12.0.2022. The European Committee on Antimicrobial Susceptibility Testing. URL: http://www.eucast.org (date of access June 19, 2024).
- Koupaei M., Asadi A., Mahdizade A.M., Seyyedi Z.S., еt al. Secondary Klebsiella pneumoniae infection in patients with COVID-19: a systematic review. Diagn Microbiol Infect Dis. 2024; 108 (2): 116105. DOI: https://doi.org/10.1016/j.diagmicrobio.2023.116105
- Huang W., Qiao F., Deng Y., Zhu S. Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study. Eur J Clin Microbiol Infect Dis. 2023; 42 (5): 529–41. DOI: https://doi.org/10.1007/s10096-023-04578‑w
- Liu Y., Huang L., Cai J., Zhuet H., et al. Clinical characteristics of respiratory tract infection caused by Klebsiella pneumoniae in immunocompromised patients: a retrospective cohort study. Front Cell Infect Microbiol. 2023; 13: 1137664. DOI: https://doi.org/10.3389/fcimb.2023.1137664
- Oliveira A.B., Sacillotto G.H., Neves M.F., Silva A.H., et al. Prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections among patients in an ICU. J Bras Pneumol. 2023; 49 (1): 20220235. DOI: https://doi.org/10.36416/1806-3756/e20220235 PMID: 36700572.